Literature DB >> 35094319

Method to Isolate Dormant Cancer Cells from Heterogeneous Populations.

Julian A Preciado1, Alptekin Aksan2.   

Abstract

Cancer recurrence is responsible for a high percentage of cancer-related deaths. Primary tumor removal, chemotherapy, and radiotherapy often leave behind cancer cells that are clinically undetectable. Recent evidence has shown that subpopulations of these residual cancer cells enter into a prolonged dormant state, remaining quiescent for months to years, and eventually lead to metastases and relapse (Sosa et al. Nat Rev Cancer 14:611-622, 2014). Identifying the presence of and isolating these dormancy-capable cells (DCCs) from resected tumors or bodily fluids may therefore provide an opportunity to understand their biology and develop personalized treatments for patients at risk for relapse. Physical confinement in a stiff and porous 3D matrix, which inhibits proliferation, migration, and growth of the immobilized cells, has been shown to isolate DCC populations (Preciado et al. Technology 05:1-10, 2017; Reátegui et al. J Mater Chem B 2:7440-7448, 2014). Isolated DCCs can then be recovered from the gel and analyzed. Here we describe this immobilization method that can be used to isolate DCCs from heterogeneous cell populations that may also include dormancy-incapable cancer cells and host cells.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer relapse; Cell immobilization; Dormant cell isolation; Physical confinement; Silica encapsulation; Single cell cancer dormancy

Mesh:

Year:  2022        PMID: 35094319     DOI: 10.1007/978-1-0716-1811-0_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

Review 1.  Multiscale requirements for bioencapsulation in medicine and biotechnology.

Authors:  Paul de Vos; Marek Bucko; Peter Gemeiner; Marián Navrátil; Juraj Svitel; Marijke Faas; Berit Løkensgard Strand; Gudmund Skjak-Braek; Yrr A Morch; Alica Vikartovská; Igor Lacík; Gabriela Kolláriková; Gorka Orive; Dennis Poncelet; Jose Luis Pedraz; Marion B Ansorge-Schumacher
Journal:  Biomaterials       Date:  2009-02-07       Impact factor: 12.479

2.  Tunable hydrogels for controlling phenotypic cancer cell states to model breast cancer dormancy and reactivation.

Authors:  Shantanu Pradhan; John H Slater
Journal:  Biomaterials       Date:  2019-05-10       Impact factor: 12.479

Review 3.  Mechanisms of disseminated cancer cell dormancy: an awakening field.

Authors:  María Soledad Sosa; Paloma Bragado; Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2014-08-14       Impact factor: 60.716

4.  Chemomechanically engineered 3D organotypic platforms of bladder cancer dormancy and reactivation.

Authors:  Taraka Sai Pavan Grandhi; Thrimoorthy Potta; Rajeshwar Nitiyanandan; Indrani Deshpande; Kaushal Rege
Journal:  Biomaterials       Date:  2017-07-07       Impact factor: 12.479

5.  A niche-dependent myeloid transcriptome signature defines dormant myeloma cells.

Authors:  Weng Hua Khoo; Guy Ledergor; Assaf Weiner; Daniel L Roden; Rachael L Terry; Michelle M McDonald; Ryan C Chai; Kim De Veirman; Katie L Owen; Khatora S Opperman; Kate Vandyke; Justine R Clark; Anja Seckinger; Natasa Kovacic; Akira Nguyen; Sindhu T Mohanty; Jessica A Pettitt; Ya Xiao; Alexander P Corr; Christine Seeliger; Mark Novotny; Roger S Lasken; Tuan V Nguyen; Babatunde O Oyajobi; Dana Aftab; Alexander Swarbrick; Belinda Parker; Duncan R Hewett; Dirk Hose; Karin Vanderkerken; Andrew C W Zannettino; Ido Amit; Tri Giang Phan; Peter I Croucher
Journal:  Blood       Date:  2019-04-25       Impact factor: 22.113

6.  A Model of Dormant-Emergent Metastatic Breast Cancer Progression Enabling Exploration of Biomarker Signatures.

Authors:  Amanda M Clark; Manu P Kumar; Sarah E Wheeler; Carissa L Young; Raman Venkataramanan; Donna B Stolz; Linda G Griffith; Douglas A Lauffenburger; Alan Wells
Journal:  Mol Cell Proteomics       Date:  2018-01-20       Impact factor: 5.911

Review 7.  Polymers in cell encapsulation from an enveloped cell perspective.

Authors:  Paul de Vos; Hamideh Aghajani Lazarjani; Denis Poncelet; Marijke M Faas
Journal:  Adv Drug Deliv Rev       Date:  2013-11-22       Impact factor: 15.470

8.  Identification of novel drugs to target dormant micrometastases.

Authors:  Robert E Hurst; Paul J Hauser; Youngjae You; Lora C Bailey-Downs; Anja Bastian; Stephen M Matthews; Jessica Thorpe; Christine Earle; Lilly Y W Bourguignon; Michael A Ihnat
Journal:  BMC Cancer       Date:  2015-05-14       Impact factor: 4.430

9.  A facile in vitro platform to study cancer cell dormancy under hypoxic microenvironments using CoCl2.

Authors:  Hak Rae Lee; Faith Leslie; Samira M Azarin
Journal:  J Biol Eng       Date:  2018-08-03       Impact factor: 4.355

10.  Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways.

Authors:  Lisly Chéry; Hung-Ming Lam; Ilsa Coleman; Bryce Lakely; Roger Coleman; Sandy Larson; Julio A Aguirre-Ghiso; Jing Xia; Roman Gulati; Peter S Nelson; Bruce Montgomery; Paul Lange; Linda A Snyder; Robert L Vessella; Colm Morrissey
Journal:  Oncotarget       Date:  2014-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.